Esperion Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ESPR and other ETFs, options, and stocks.

About ESPR

Esperion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. 

CEO
Sheldon L. Koenig
CEOSheldon L. Koenig
Employees
294
Employees294
Headquarters
Ann Arbor, Michigan
HeadquartersAnn Arbor, Michigan
Founded
1998
Founded1998
Employees
294
Employees294

ESPR Key Statistics

Market cap
807.05M
Market cap807.05M
Price-Earnings ratio
-30.24
Price-Earnings ratio-30.24
Dividend yield
Dividend yield
Average volume
8.18M
Average volume8.18M
High today
$3.14
High today$3.14
Low today
$3.12
Low today$3.12
Open price
$3.13
Open price$3.13
Volume
10.76M
Volume10.76M
52 Week high
$4.18
52 Week high$4.18
52 Week low
$0.85
52 Week low$0.85

Stock Snapshot

As of today, Esperion Therapeutics(ESPR) shares are valued at $3.14. The company's market cap stands at 807.05M, with a P/E ratio of -30.24.

As of 2026-06-02, Esperion Therapeutics(ESPR) stock has fluctuated between $3.12 and $3.14. The current price stands at $3.14, placing the stock +0.5% above today's low and -0.2% off the high.

The Esperion Therapeutics(ESPR)'s current trading volume is 10.76M, compared to an average daily volume of 8.18M.

During the past year, Esperion Therapeutics(ESPR) stock moved between $0.85 at its lowest and $4.18 at its peak.

During the past year, Esperion Therapeutics(ESPR) stock moved between $0.85 at its lowest and $4.18 at its peak.

ESPR News

TipRanks 19h
Esperion Shareholders Approve Directors, Pay, and Equity Plan

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

Analyst ratings

86%

of 7 ratings
Buy
0%
Hold
85.7%
Sell
14.3%

People also own

Based on the portfolios of people who own ESPR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.